Rapid Complexation of Aptamers by Their Specific Antidotes
AbstractNucleic acid ligands, aptamers, harbor the unique characteristics of small molecules and antibodies. The specificity and high affinity of aptamers enable their binding to different targets, such as small molecules, proteins, or cells. Chemical modifications of aptamers allow increased bioavailability. A further great benefit of aptamers is the antidote (AD)-mediated controllability of their effect. In this study, the AD-mediated complexation and neutralization of the thrombin binding aptamer NU172 and Toll-like receptor 9 (TLR9) binding R10-60 aptamer were determined. Thereby, the required time for the generation of aptamer/AD-complexes was analyzed at 37 °C in human serum using gel electrophoresis. Afterwards, the blocking of aptamers’ effects was analyzed by determining the activated clotting time (ACT) in the case of the NU172 aptamer, or the expression of immune activation related genes IFN-1β, IL-6, CXCL-10, and IL-1β in the case of the R10-60 aptamer. Gel electrophoresis analyses demonstrated the rapid complexation of the NU172 and R10-60 aptamers by complementary AD binding after just 2 min of incubation in human serum. A rapid neutralization of anticoagulant activity of NU172 was also demonstrated in fresh human whole blood 5 min after addition of AD. Furthermore, the TLR9-mediated activation of PMDC05 cells was interrupted after the addition of the R10-60 AD. Using these two different aptamers, the rapid antagonizability of the aptamers was demonstrated in different environments; whole blood containing numerous proteins, cells, and different small molecules, serum, or cell culture media. Thus, nucleic acid ADs are promising molecules, which offer several possibilities for different in vivo applications, such as antagonizing aptamer-based drugs, immobilization, or delivery of oligonucleotides to defined locations. View Full-Text
Share & Cite This Article
Stoll, H.; Steinle, H.; Wilhelm, N.; Hann, L.; Kunnakattu, S.-J.; Narita, M.; Schlensak, C.; Wendel, H.P.; Avci-Adali, M. Rapid Complexation of Aptamers by Their Specific Antidotes. Molecules 2017, 22, 954.
Stoll H, Steinle H, Wilhelm N, Hann L, Kunnakattu S-J, Narita M, Schlensak C, Wendel HP, Avci-Adali M. Rapid Complexation of Aptamers by Their Specific Antidotes. Molecules. 2017; 22(6):954.Chicago/Turabian Style
Stoll, Heidi; Steinle, Heidrun; Wilhelm, Nadja; Hann, Ludmilla; Kunnakattu, Silju-John; Narita, Miwako; Schlensak, Christian; Wendel, Hans P.; Avci-Adali, Meltem. 2017. "Rapid Complexation of Aptamers by Their Specific Antidotes." Molecules 22, no. 6: 954.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.